Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Charles River Laboratories International, Inc. CRL

Healthcare  —  Diagnostics & Research
292.84 (1.60) (0.54%) as of 25 Sep
Market cap
$14.1B
P/E
0.0×
S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Charles River Laboratories International, Inc. (CRL) P/E ratio

Charles River Laboratories International, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (September 2026) to 1,056× (January 2025) — the current reading is the lowest in ten years.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 0.0× —
FY2024 1,026× 3,954.06%
FY2023 25.3× 10.85%
FY2022 22.8× (52.94%)
FY2021 48.5× 42.45%
FY2020 34.0× 15.21%
FY2019 29.5× 22.70%
FY2018 24.1× (43.63%)
FY2017 42.7× 84.22%
FY2016 23.2× (7.40%)

Quarterly

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 1,056×
Ten-year median 26.6×
Current reading's percentile 13

P/E ratio against peers

Company P/E ratio
CRL Charles River Laboratories International, Inc. n/m
GH Guardant Health, Inc. compare n/m
TWST Twist Bioscience Corporation compare n/m
QGEN QIAGEN N.V. compare 22.6×
DGX Quest Diagnostics Incorporated compare 24.8×
LH Labcorp Holdings Inc. compare 25.4×
MEDP Medpace Holdings, Inc. compare 35.6×
RVTY Revvity Inc. compare 72.0×
ICLR ICON PLC compare 257×
Diagnostics & Research industry median 33.9×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on CRL